Royal Bank of Canada lowered Aptiv's target price from $86.00 to $85.00, while other analysts also adjusted their targets.

Royal Bank of Canada reduced its target price for Aptiv from $86.00 to $85.00, maintaining an outperform rating. Aptiv reported Q2 EPS of $1.58, surpassing the consensus estimate of $1.42 by $0.16. Other analysts also made price adjustments, including Goldman Sachs Group lowering its target from $118.00 to $101.00, and Citigroup cutting its price objective from $128.00 to $108.00. Aptiv's revenue for Q2 was $5.05 billion, lower than analyst estimates of $5.30 billion.

August 18, 2024
3 Articles